US Stem Cell Inc (USRM)

[Dragon Lady]

""We are very pleased to enter into these agreements with Magna. These financings help Bioheart proceed with our trials efforts and continue our pursuit to take our therapies to the bedside."--Mike Tomás"

The LATEST, just recent, LEGALLY, SEC FILED, CEO SIGNED, 10-Q, AFTER that above statement was made:

PAGE 29:
"We are seeking to secure sufficient funds to reinitiate enrollment in the MARVEL and REGEN trials. If we successfully secure such funds, we intend to re-engage a contract research organization, or CRO, investigators and certain suppliers to advance such trials. We have initiated and enrolled our first patient in the MIRROR trial in 2013. The trial is very similar to the MARVEL trial but focusses on sites outside the US. We will continue enrollment in the MIRROR trial once we have secured sufficient funds."

Why's that statement STILL in that 10-Q, just filed? Why? Why would it still be in there?